Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Equity (2019 - 2025)

Silo Pharma (SILO) has disclosed Return on Equity for 7 consecutive years, with 0.75% as the latest value for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.75% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.75% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.75% for FY2025, 4.0% up from the prior year.
  • Return on Equity hit 0.75% in Q4 2025 for Silo Pharma, up from 1.02% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.03% in Q2 2022 to a low of 1.1% in Q2 2025.
  • Historically, Return on Equity has averaged 0.43% across 5 years, with a median of 0.46% in 2021.
  • Biggest YoY gain for Return on Equity was 171bps in 2021; the steepest drop was -784bps in 2021.
  • Year by year, Return on Equity stood at 0.01% in 2021, then crashed by -101bps to 0.0% in 2022, then plummeted by -633182bps to 0.66% in 2023, then fell by -12bps to 0.74% in 2024, then fell by -1bps to 0.75% in 2025.
  • Business Quant data shows Return on Equity for SILO at 0.75% in Q4 2025, 1.02% in Q3 2025, and 1.1% in Q2 2025.